# Prevention of Docetaxel Induced Dacryostenosis

> **NCT00266838** · PHASE1 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 20 (estimated)

## Conditions studied

- Epiphora

## Interventions

- **DRUG:** Maxidex; Lacrystat

## Key facts

- **NCT ID:** NCT00266838
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-05
- **Final completion:** 2009-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00266838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00266838, "Prevention of Docetaxel Induced Dacryostenosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00266838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*